ABG
ISEE

Ally Bridge Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Ally Bridge Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-255,310
Closed -$6.21M – 24
2023
Q1 		$6.21M Buy
+255,310
New +$5.59M 8.14% 6
2022
Q3 		– Sell
-650,000
Closed -$6.25M – 51
2022
Q2 		$6.25M Hold
650,000
– – 5.7% 6
2022
Q1 		$10.9M Buy
650,000
+100,000
+18% +$1.48M 8.11% 2
2021
Q4 		$9.2M Buy
550,000
+300,000
+120% +$4.92M 3.21% 16
2021
Q3 		$4.06M Buy
+250,000
New +$2.72M 1.19% 27

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Ally Bridge Group's ISEE Position: Q2 2023 in Review

Ally Bridge Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 255,310 shares — an estimated $6.21M sold.

Ally Bridge Group first reported a position in ISEE in Q3 2021 and held it in 5 quarters. The position peaked at $10.9M in Q1 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Ally Bridge Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ally Bridge Group sold 255,310 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $6.21M.
  • Ally Bridge Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Ally Bridge Group's IVERIC bio, Inc. Common Stock position peaked at $10.9M in Q1 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Ally Bridge Group's 13F filing for Q2 2023, filed 14 Aug 2023.